Natalizumab treatment and pregnancy in multiple sclerosis: A reappraisal of maternal and infant outcomes after 6 years. Portaccio E, Pasto L, Razzolini L, Moiola L, et al. Mult Scler 2022 Mar 16:13524585221079598. doi: 10.1177/13524585221079598.

Read + Share

Amedeo Smart

Independent Medical Education

Portaccio E, Pasto L, Razzolini L, Moiola L, et al. Natalizumab treatment and pregnancy in multiple sclerosis: A reappraisal of maternal and infant outcomes after 6 years. Mult Scler 2022 Mar 16:13524585221079598. doi: 10.1177/13524585221079598.
PMID: 35296189